newsfilter
← Latest News
GlobeNewswire·

InMed Announces Share Consolidation to Meet Nasdaq Listing Criteria

VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces, pursuan